Why AF for revalidation

AF is particularly well suited to the preparation of portfolio content in preparation for revalidation. The principal reasons for this are:

  • A manageable number of AF patients on a typical GP list
  • A high likelihood that a significant proportion is not receiving ideal treatment
  • The ability to make simple changes to management that will reduce stroke risk; preventing death and disability
  • Considerable recent development in the accuracy of stroke risk stratification
  • Recent clarification of treatment recommendations in guidelines, consensus statement and the wider published literature
  • The recent addition of several new, cost-effective treatment options
  • A free and ready-made audit tool that can be deployed within minutes via PRIMIS+
  • Inclusion of directly-relevant AF indicators in the QOF
  • The imminent updating of NICE guidance on AF

"AF is an ideal condition, which lends itself to be audited for the purposes of revalidation. First of all, every practice has enough AF patients but still a number which is manageable ... and, because the stroke risk is so high, by treating a relatively small number of patients you can very quickly see the benefit in stroke risk reduction."
Dr Andreas Wolff


The video clips on this page explain more about each of these points:

  • Welcome: hear about the goals of the AF Revalidation tool and the suitability of AF as an area of focus when preparing for revalidation
  • Aspirin Myth: hear about the implications for primary care of Professor Lip’s lecture
  • Audit with GRASP-AF: learn just how easily you AF patients can be audited with a simple and free tool
  • QOF, NICE and AF: hear about the relevant QOF indicators and the likely changes in revised NICE guidance
  • CHADS2 and CHADSVASc: learn about risk stratification and recent developments that clarify treatment options